Erasmus School of Health Policy & Management

2023

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe

Vancoppenolle, J. M., Koole, S. N., O'Mahony, J. F., Franzen, N., Burgers, J. A., Retèl, V. P. & van Harten, W. H., Aug 2023, In: Drug Discovery Today. 28, 8, p. 1-5 5 p., 103620.

Research output: Contribution to journal › Short survey › Academic › peer-review

Open Access

File

1 Citation (Scopus)

18 Downloads (Pure)

2019

Impact of organ-on-a-chip technology on pharmaceutical R&D costs

Franzen, N., van Harten, W. H., Retèl, V. P., Loskill, P., van den Eijnden-van Raaij, J. & IJzerman, M., Sept 2019, In: Drug Discovery Today. 24, 9, p. 1720-1724 5 p.

Research output: Contribution to journal › Short survey › Academic › peer-review

Open Access

File

110 Citations (Scopus)

101 Downloads (Pure)

2011

Nieuwe geneesmiddelen: Niet goed, geld terug?

Translated title of the contribution: New drugs: Not good, money back?Steenhoek, A., Koopmanschap, M. A., Franken, M. G. & Rutten, F. F. H., 22 Jan 2011, In: Nederlands Tijdschrift voor Geneeskunde. 155, 3, p. 130-134 5 p.

Research output: Contribution to journal › Short survey › Popular

2003

Universal chickenpox vaccination of infants may be cost-saving to society, but better studies are needed

Thiry, N., Beutels, P., Van Dammel, P., Van Doorslaer, E., Siriwardena, A. N. & Sabella, C., 2003, In: Evidence-Based Healthcare. 7, 3, p. 148-150 3 p.